Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Various Advanced Cancer”

41 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 41 results

Not applicableWithdrawnNCT04889495
What this trial is testing

A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer

Who this might be right for
Non-small Cell Lung CancerMetastatic Colorectal CancerMetastatic Breast Cancer+5 more
Pfizer
Testing effectiveness (Phase 2)Study completedNCT03130959
What this trial is testing

Evaluate the Safety and Efficacy of Nivolumab Monotherapy and Nivolumab in Combination With Ipilimumab in Pediatric Participants With High Grade Primary Central Nervous System (CNS) Malignancies

Who this might be right for
Various Advanced Cancer
Bristol-Myers Squibb 166
Early research (Phase 1)UnknownNCT04849247
What this trial is testing

68Ga-DOTA-FAPI and 177Lu-DOTA-FAPI Theranostic Pair in Patients With Various Types of Cancer (Locally Advanced or Metastatic Cancer)

Who this might be right for
177Lu-DOTA-FAPI68Ga-DOTA-FAPITheranostic
The First Affiliated Hospital of Xiamen University 30
Early research (Phase 1)Study completedNCT01673737
What this trial is testing

A Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced Cancer

Who this might be right for
Neoplasm Malignant
Sanofi 75
Early research (Phase 1)Study completedNCT03335540
What this trial is testing

An Adaptive Study to Match Patients With Solid Tumors to Various Immunotherapy Combinations Based Upon a Broad Biomarker Assessment

Who this might be right for
Advanced Cancer
Bristol-Myers Squibb 20
Testing effectiveness (Phase 2)Study completedNCT01700049
What this trial is testing

Study Evaluating the Efficacy of Oral Vismodegib in Various Histologic Subtypes

Who this might be right for
Basal Cell Carcinoma
Mayo Clinic 28
Testing effectiveness (Phase 2)Study completedNCT02387996
What this trial is testing

Nivolumab in Participants With Metastatic or Unresectable Bladder Cancer

Who this might be right for
Various Advanced Cancer
Bristol-Myers Squibb 270
Not applicableStudy completedNCT03350529
What this trial is testing

MRI Guided Transurethral HIFU for Various Prostate Diseases

Who this might be right for
Localised Prostate CancerLocally Advanced Prostate CancerLocally Recurrent Prostate Cancer+1 more
Turku University Hospital 87
Not applicableLooking for participantsNCT05443087
What this trial is testing

TARGETed Therapy Drug MONITOring in DIGestive Oncology

Who this might be right for
Digestive CancerMetastatic Colorectal CancerHepatocellular Carcinoma+2 more
UNICANCER 330
Early research (Phase 1)Study completedNCT00701324
What this trial is testing

BI 811283 in Various Solid Tumours

Who this might be right for
Neoplasms
Boehringer Ingelheim 124
Early research (Phase 1)Study completedNCT01335269
What this trial is testing

BI 853520 in Patients With Various Types of Advanced or Metastatic Cancer

Who this might be right for
Neoplasms
Boehringer Ingelheim 96
Testing effectiveness (Phase 2)Active Not RecruitingNCT05676931
What this trial is testing

Study With Various Immunotherapy Treatments in Participants With Lung Cancer

Who this might be right for
Advanced Non-Small Cell Lung Cancer
Gilead Sciences 400
Not applicableLooking for participantsNCT07312760
What this trial is testing

Existential Distress in Advanced Cancer: Comparing a Short-term Psychodynamic Psychotherapy (ORPHYS) to Treatment as Usual (TAU)

Who this might be right for
Advanced Cancer, Various, NOS
Universitätsklinikum Hamburg-Eppendorf 160
Early research (Phase 1)Study completedNCT01938846
What this trial is testing

BI 860585 Dose Escalation Single Agent and in Combination With Exemestane or With Paclitaxel in Patients With Various Advanced and/or Metastatic Solid Tumors

Who this might be right for
Neoplasms
Boehringer Ingelheim 90
Large-scale testing (Phase 3)Active Not RecruitingNCT02632409
What this trial is testing

An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer

Who this might be right for
Various Advanced Cancer
Bristol-Myers Squibb 709
Testing effectiveness (Phase 2)UnknownNCT02689167
What this trial is testing

Study to Assess Various Sunitinib Schedules in Renal Cell Carcinoma

Who this might be right for
Kidney NeoplasmsMetastatic Renal Cell Cancer
Centre Hospitalier Universitaire de Besancon 226
Early research (Phase 1)Study completedNCT01007968
What this trial is testing

Pharmacokinetics and Safety of Panobinostat in Patients With Advanced Solid Tumors and Various Degrees of Hepatic Function

Who this might be right for
Advanced Solid Tumors
Novartis Pharmaceuticals 25
Testing effectiveness (Phase 2)Study completedNCT02488759
What this trial is testing

An Investigational Immuno-therapy Study to Investigate the Safety and Effectiveness of Nivolumab, and Nivolumab Combination Therapy in Virus-associated Tumors

Who this might be right for
Various Advanced Cancer
Bristol-Myers Squibb 578
Early research (Phase 1)Study completedNCT01905111
What this trial is testing

BI 853520 in Japanese and Taiwanese Patients With Various Types of Advanced or Metastatic Cancer

Who this might be right for
Neoplasms
Boehringer Ingelheim 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT03473743
What this trial is testing

Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer

Who this might be right for
Urothelial Carcinoma
Janssen Research & Development, LLC 125
Load More Results